An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Several professionals stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the service has taken down violative content and prohibited related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.
After moments of joining one community, a seller posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Item Information and Costs
Within these communities, posts display black plastic parcels with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly significant medical dangers”.
